Robot-assisted vs. laparoscopic cholecystectomy in children: a meta-analysis with systematic review of comparative studies Authors: Maria Klimeczek-Chrapusta, Kacper Stolarz, Bartosz Gęgała, Alicja Kot, Zofia Łubniewska, Maciej Preinl, Bartosz Bogusz, Maria Gruba, Anna Dąbrowska, Wojciech Górecki Published: 2025 ABSTRACT AbstractThis meta-analysis aimed to compare the safety and effectiveness of robot-assisted cholecystectomy (RAC) versus laparoscopic cholecystectomy (LC). A comprehensive search of online databases was carried out to identify studies comparing laparoscopic cholecystectomy (LC) with robot-assisted cholecystectomy (RAC). Safety outcomes assessed included operative complications and conversion rates, while efficacy parameters comprised length of hospital stay, total operative time, postoperative analgesic use, and procedure cost. The meta-analysis was conducted using a random-effects model. A total of 157 articles were screened, 5 studies meeting the inclusion criteria, encompassing 548 children. Included studies reported instances of shorter LOS, reduced analgesic requirements, lower conversion and reintervention rates, and fewer postoperative complications in the RAC groups; however, none of these differences reached statistical significance. This meta-analysis found no meaningful differences between RAC and LC regarding safety and efficacy outcomes, suggesting that RAC is comparable to LC in the pediatric population.Supplementary InformationThe online version contains supplementary material available at 10.1007/s11701-025-03053-2.Keywords: Pediatric surgery, Robotic surgery, Cholecystectomy, Laparoscopy Introduction Laparoscopic cholecystectomy (LC) has been the standard treatment for children with symptomatic gallstones or biliary dyskinesia [1, 2]. Compared to traditional open surgery, it offers quicker recovery times and less common postoperative complications. In recent years minimally invasive surgery techniques have been revolutionized by rising access to robotic surgery. Robot-assisted cholecystectomy (RAC) seems to offer benefits in precision, better three-dimensional visualization and improved surgical control. Furthermore, in the studies included this following study, RAC was most commonly performed using a single-site procedure which compared to traditional multi-port laparoscopic techniques offers reduced post-surgical incision pain and more desirable cosmetic outcome [3]. While single-site procedures are also possible in LC, the multiport approach remains a gold standard in laparoscopic cholecystectomy [4, 5]. The objective of this meta-analysis was to assess the safety and efficacy of laparoscopic versus robotic cholecystectomy in pediatric patients, with particular emphasis on postoperative and intraoperative complications, conversion rates, duration of hospitalization, operative time and analgesic needs. To the best of our knowledge, this is the first published meta-analysis addressing this topic in children. Both surgical approaches have been shown to be effective; however, their respective advantages and limitations remain a subject of debate as researchers strive to identify which method offers superior outcomes [1–3]. By incorporating data from various studies, we hope to bring some insight into the aspects that may influence the choice of technique based on both clinical and financial factors. Methods The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [6] criteria were closely followed by the authors of this meta-analysis. Additionally, the review was listed in the PROSPERO database under the registration number CRD42024584606. As a systematic review with meta-analysis, this study did not require ethical approval or participant informed consent to be conducted. Search strategy A thorough literature search was performed in October 2024 across three major electronic databases: MEDLINE/PubMed, EMBASE, and Web of Science. No limitations were placed on publication date or language. The search query applied in MEDLINE/PubMed was as follows: ("Surgery, Computer-Assisted"[MeSH] OR “robotics”[MeSH] OR “da Vinci” OR “telerobotic” OR “telesurgery” OR “robotic surgery”) AND (“Pediatrics”[MeSH] OR “Infant”[MeSH] OR “Child”[MeSH] OR “Adolescent”[MeSH]) AND (“Cholecystectomy”[MeSH] OR “Cholelithiasis” OR “gallbladder” OR “gallstones”[MeSH]). Taking into account the specific syntax rules of each database, the search strategies for the remaining databases followed the same overall structure. Once the full-text articles were selected, their reference lists were manually examined to identify any additional relevant studies that could be eligible for inclusion. Inclusion and exclusion criteria The analysis encompassed pertinent research contrasting any aspects of traditional LC versus RAC in pediatric patients. Eligible studies met the following criteria: (1) original clinical research directly comparing robot-assisted and conventional laparoscopic cholecystectomy in pediatric populations (< 18 years), and (2) reporting relevant outcomes such as operative duration, hospital stay length, morphine use, conversion to open surgery, and intraoperative or postoperative complications. These were the criteria for exclusion: (1) presence of children and adults in the study population who cannot be distinguished from one another; (2) studies focusing solely on RAC or LC approach for cholecystectomy; (3) inappropriate study type, i.e., conference reports, case reports, reviews, and meta-analyses. At least two authors independently conducted blind reviews of each paper deemed suitable for inclusion in this meta-analysis. If there were any disagreements, all authors had to discuss them thoroughly in order to reach a consensus. Extraction strategy Two authors independently extracted data from the included studies using a standardized electronic spreadsheet. For continuous variables, the analysis required the number of participants, mean values, and corresponding standard deviations (SD). In cases where SDs were not provided, they were approximated using established methods, such as SD = range / 4 or SD = interquartile range / 1.35. Study quality appraisal After the blind review, all papers that satisfied the inclusion criteria underwent a quality assessment. Randomized research was assessed using the Cochrane risk-of-bias instrument (RoB), whereas non-randomized studies were analyzed using the Newcastle–Ottawa Quality Assessment for Cohort Studies (NOS). The quality assessment procedure was carried out separately by two authors. No study was excluded from this meta-analysis due to its poor quality. Outcomes of interest Information extracted from each study included the research design (randomized controlled trial [RCT], cohort study [CS], or case–control study [CCS]), name of the first author, year of publication, and population details (sample size, country, age, and sex). Data on both the laparoscopic cholecystectomy (LC) and robot-assisted cholecystectomy (RAC) groups were also collected, encompassing patient demographics (number, age, sex, weight) and clinical parameters such as operative time (OT), hospital stay (LOS), morphine use, conversion rate to open surgery, and intra- or postoperative complication rates. Variables or complications reported in only a single study were excluded from the analysis. Statistical methodology The meta-analysis focused on the following outcomes: operative time, length of hospital stay, morphine consumption, conversion rate to open surgery, and rates of intraoperative and postoperative complications. All statistical analyses were conducted using PS IMAGE PRO 10.0 (IBM SPSS Statistics 29.0.2). For continuous variables, the standardized mean difference (SMD) served as the effect size, while dichotomous variables were analyzed using the log odds ratio (LogOR). Each outcome was presented with a 95% confidence interval (CI).Heterogeneity among studies was assessed using both the Chi2 and I2 statistics. Based on I2 values, heterogeneity was interpreted as follows: 0–40% likely insignificant, 30–60% moderate, 50–90% substantial, and 75–100% considerable. A random-effects model was applied throughout all analyses. Statistical significance was set at p < 0.05 for comparisons of continuous and categorical data, and p < 0.1 for heterogeneity testing. The main results were visualized using forest plots. Systematic literature review A descriptive analysis was performed for all included studies. The evaluation covered multiple domains, such as study design and characteristics (including year of publication, country, sample size, study groups, duration, and follow-up period), type of robotic system utilized, investigated parameters, principal results, as well as reported complications and conversion rates. Results Acquiring the studies The database search revealed 157 unique references after the duplicates were eliminated. Citation searching yielded an additional seven. Eventually, 36 papers were assessed in full text. A total of five studies [1, 3, 7–9] were included in this meta-analysis following the eligibility assessment. Fig. 1 displays the PRISMA flowchart outlining the inclusion process. PRISMA flowchart depicting the data gathering process Quality assessment The quality of the included studies was evaluated using the NOS. The quality of all six studies was ranked as good. The evidence was weakest for outcomes, particularly follow-up duration. As none of the studies were randomized, the Cochrane RoB tool was not applied. Details are summarized in Table 1. Table 1Study quality for non-randomized investigations included in the meta-analysis was evaluated with the newcastle–ottawa scale (NOS)StudySelectionComparabilityOutcomeStudy qualityRepresentativeness of the exposed cohortSelection of the non-exposed cohortAscertainment of exposureDemonstration that outcome of interest was not present at start of studyComparability of cohortsAssessment of outcomeSufficent follow-up timeAdequacy of follow-up of cohortsMain factorAdditional factorMattei, 2017 [7]**0*****0GoodNolan and Glenn 2018 [1]*0******0GoodKulaylat and Richards et al 2021 [3]*********GoodSvetanoff and Diefenbach et al [8]*********GoodWallace and Ram et al [9]*********Good*high quality choices/ 0- low quality choices Study quality for non-randomized investigations included in the meta-analysis was evaluated with the newcastle–ottawa scale (NOS) *high quality choices/ 0- low quality choices The characteristics of the included studies This meta-analysis encompassed data from 548 pediatric patients across six studies conducted between 2015 and 2024, all originating from the United States. The primary outcomes analyzed included operative time (reported in five studies), hospital stay duration (five studies), morphine consumption (three studies), conversion to open surgery (two studies), intra- and postoperative complication rates (three studies), and reintervention frequency (two studies). The detailed characteristics of the included studies are summarized in Table 2. Table 2Characteristics of the included studiesStudy IDCountryData collection processN of patients who underwent CholecystectomyN of patients in the robot groupN of patients in the laparoscopy groupAGE (yrs) of patients in the robot groupAGE (yrs) of patients in the laparoscopy groupWEIGHT (kg) of patients in the robot groupWEIGHT (kg) of patients in the laparoscopy groupMattei, 2017 [7]USARetrospective40202016.0 ± 2.2 (11–20)17.3 ± 2.6 (13–24)75.0 ± 19.2 (51.5–145.1)68.0 ± 21.4 (42–118.3)Nolan, and Glenn 2018 [1]USARetrospective (RSI vs LSI)7110 (RSI)20 (LSI)13.8 (± 3.0)13.9 (± 2.7)66.2 (± 15.9)65.3 (± 18.1)Retrospective (LMP vs RMP)11 (RMP)30 (LMP)14.7 (± 1.8)13.4 (± 3.5)80.3 (± 22.3)68.5 (± 26.0)Kulaylat, and Richards et al 2021 [3]USARetrospective2997922015.4 (14.3–17.1)15.6 (13.5–16.8)BMI 27.5 (20.7–34.3)BMI 26 (20.2–31.9)Svetanoff and Diefenbach et al 2024 [8]USARetrospective50252515.7 (14.7–17.3)15.3 (14.5–16.9)92.6 (60–105.9)72.3 (61.6–85.6)Wallace and Ram et al 2024USARetrospective88246416,1 (15–16.0915,3 (13.8–16.2)36.7 (27.4–44.2)32.8 (27.9–38.8)n/a—no data, RSI- robotic single incision, LSI- laparoscopic single incision, RMP- robotic multiport, LMP- laparoscopic multiport Characteristics of the included studies n/a—no data, RSI- robotic single incision, LSI- laparoscopic single incision, RMP- robotic multiport, LMP- laparoscopic multiport Description of the population A total of 548 patients (349 females, 111 males, and 88 participants without sex data) were included in the study. Conventional LC was performed in 376 patients, while 169 patients underwent RAC. The populations of the experimental (RAC) and control (LC) groups were homogeneous and comparable. The results showed no statistically significant difference in patient age between the two groups [Fig. 2] (SMD = -0.02; 95% CI: -0.27 to 0.23; p = 0.87). A statistically significant difference in patients’ weight was observed [Fig. 3] (SMD = 0.37; 95% CI: 0.10–0.64; p = 0.01); children who underwent robotic cholecystectomy had a significantly higher weight. Despite females constituting over a trifold of male participants, no significant difference in female [Fig. 4] (LogOR = -0.16; 95%CI: -0.65–0.33; p = 0.52) nor male [Fig. 5] (LogOR = 0.16; 95%CI: -0.33–0.65; p = 0.52) incidence was found between respective control and treatment groups. Forest plot showing the comparison of patient age between the robotic-assisted cholecystectomy (RAC) and laparoscopic cholecystectomy (LC) groups Forest plot illustrating the patients’ weight in the robotic-assisted (RAC) and laparoscopic (LC) cholecystectomy groups Forest plot presenting the female ratio between RAC and LC groups Forest plot presenting the male ratio between RAC and LC groups Systematic review Descriptive analysis was performed for all included studies. Data was extracted and organized into the following categories: study characteristics (year, country, design, study arms, sample size, study period, robot system used, and follow-up duration), analyzed variables, primary results, postoperative complications, and conversion rates. A summary of these findings is presented in Tables 1 and 3. Table 3Systematic review of the included studiesAuthor, yearCountrySample sizeTime periodRobot typeTechniqueFollow up periodAnalysed variablesMain resultsComplicationsConversionsMattei, 2017 [7]USA402013 to 2017da Vinci Surgical robot from intuitive SurgicalLaparoscopic multiport (20), single site robotic (20)30 daysoperative time, duration of hospital stay, patient age, body weight, number of intravenous opioid doses given, incidence of postoperative complications, frequency of unplanned surgical reinterventions, and rate of unplanned hospital readmissionsBoth groups were comparable in terms of patient characteristics and surgical indications. they received equivalent amounts of intravenous opioids. However, the duration of the robotic procedures was longerRAS: 4 patietients developed a wound seroma that drained spontaneously. One of these patients was treated empirically for cellulitis despite negative wound cultures laparoscopy: 0Laparoscopic: 0 RAS: 0Nolan, and Glenn 2018 [1]USA71October 2010 to December 2014n/amultiport laparoscopic (30), single-incision laparoscopic (20), multiport robotic (11), and single-incision robotic (10)n/aPatient sex and age, weight, operative time, postoperative length of stay, postoperative pain medication useOperative times were similar for laparoscopic multiport and robotic single-incision, while laparoscopic single-incision was the most time consuming. the lenght of stay after the operation was similar in each group except the robotic single incision group which was significantly shorterLaparoscopy: 0, RAS: 0Single incision laparoscopy to Multiport laparoscopy: 3 RAS to open: 0Kulayat, and Richards et al 2021 [3]USA2991 January 2015 to 31 December 2018da Vinci Surgical robot from intuitive Surgicalmultiport laparoscopic (220), single site robotic (66), multiport robotic (13)30 daysPatient sex and age, race, payor, BMI, comorbidities, clinical diagnosis, operative year, operative and postoperative outcomes, the occurrence complications, 30-days readmission, postoperative pain management, costOperating time (OT): RAS group longer OT median 98, compared to 79 min for laparoscopy (p < 0.001). Robotic cholecystectomy was associated with higher total hospital costs compared to laparoscopic cholecystectomy ($15,519 vs $11,197)Laparoscopy: 9 RAS: 6Laparoscopic: 2 RAS: 0Svetanoff and Diefenbach et al [8]USA50June 2017–June 2022da Vinci Surgical robot from intuitive SurgicaLaparoscopic multiport (25), single site robotic (24), multiport robotic (1)30 daysPatient sex and age, weight, operative time, postoperative length of stay, postoperative pain medication useRobotic approach for acute pathology prompting hospital admission can be performed safely in the pediatric population with comparable perioperative and 30-day outcomes. Opioid utilization was higher in the RAS cohort overall, no differences were detected during an analysis of the most recent 2 yearsLaparoscopy: 1 patient required post-op ERCP,1 developed pneumonia, 1 was readmitted for pancreatitis and 1 developed a readmission for pancreatitis urinary tract infectionRAS:1 patient required post-op ERCP,1was readmitted for pancreatitis and 3 developed a superficial surgical site infectionLaparoscopic: 0 RAS: 0Wallace and Ram et al 2024USA88Augusr 2020- October 2021Da Vinci Xi dual-consolen/arobotic group: 43.45 ± 30.38 dayslaparoscopic group: 33.69 ± 18.56 daysDemographics: age, height, weight, BMI, ASA-PSOperative: procedure duration, conversion to openPost-op: ICU admission, hospital length of stay (LOS), discharge opioid requirement (MME), follow-up interval, readmission, surgical site infection (SSI), bile duct injury (BDI), 30-day mortalityThere were no statistically significant differences between the groups in operative time, opioid use at discharge, readmission rates, surgical site infections (SSI), or bile duct injuries (BDI)Hospital stay was significantly shorter for the robotic cholecystectomy (RC) group (0.08 ± 0.28 days) compared to the laparoscopic cholecystectomy (LC) group (0.34 ± 0.51 days; p = 0.01)No patients in either group required ICU admission, and there were no reported deathsRobotic surgery group: 0Laparoscopic surgery group: 1 single-night readmission for pain controlLaparoscopic: 0Robotic: 0*ERCP -Endoscopic Retrograde Cholangio Pancreatography Systematic review of the included studies Laparoscopy: 1 patient required post-op ERCP, 1 developed pneumonia, 1 was readmitted for pancreatitis and 1 developed a readmission for pancreatitis urinary tract infection RAS: 1 patient required post-op ERCP, 1was readmitted for pancreatitis and 3 developed a superficial surgical site infection robotic group: 43.45 ± 30.38 days laparoscopic group: 33.69 ± 18.56 days Demographics: age, height, weight, BMI, ASA-PS Operative: procedure duration, conversion to open Post-op: ICU admission, hospital length of stay (LOS), discharge opioid requirement (MME), follow-up interval, readmission, surgical site infection (SSI), bile duct injury (BDI), 30-day mortality There were no statistically significant differences between the groups in operative time, opioid use at discharge, readmission rates, surgical site infections (SSI), or bile duct injuries (BDI) Hospital stay was significantly shorter for the robotic cholecystectomy (RC) group (0.08 ± 0.28 days) compared to the laparoscopic cholecystectomy (LC) group (0.34 ± 0.51 days; p = 0.01) No patients in either group required ICU admission, and there were no reported deaths Robotic surgery group: 0 Laparoscopic surgery group: 1 single-night readmission for pain control Laparoscopic: 0 Robotic: 0 *ERCP -Endoscopic Retrograde Cholangio Pancreatography Operating time, conversion to open surgery, complications, and reintervention rates There was no statistically significant difference between the groups in the OT analysis [Fig. 6], which comprised 548 patients (SMD = 0.51; 95%CI: -0.27–1.28; p = 0.20). Furthermore, an analysis based on 329 patients revealed no noticeable difference in the conversion rate to open surgery (LogOR = -1.01; 95%CI: -3.17–1.14; p = 0.36) [Fig. 7]. Since there was only one study that documented intraoperative complications [3], it was not feasible to perform a meta-analysis on this outcome. Both groups experienced postoperative complications (LogOR = -0.13; 95%CI: -1.91–1.65; p = 0.89) [Fig. 8] and required reinterventions (LogOR = -0.63; 95%CI: -2.20–0.94; p = 0.43) [Fig. 9] at comparable rates. Forest plot illustrating the comparison of operative time between robotic-assisted (RAC) and laparoscopic (LC) cholecystectomy Forest plot depicting the comparison of conversion rates to open surgery between laparoscopic (LC) and robot-assisted (RAC) cholecystectomy. Although the RAC group demonstrated a reduced conversion rate, the difference was not statistically significant Forest plot illustrating post operative complication rates in laparoscopic (LC) versus robotic-assisted (RAC) cholecystectomy. The robotic-assisted group demonstrated a lower post-operative complication rate; however, the difference did not reach statistical significance Forest plot comparing reintervention rates between LC and RAC groups. reinterventions were less frequent in the robotic-assisted group, but the difference was not statistically significant Hospital stay and morphine use The LOS analysis [Fig. 10], which was performed on 460 patients, showed no statistically significant difference between the groups (SMD = -0.17; 95%CI: -0.53–0.18; p = 0.33). The 111-patient analysis did not demonstrate a significant difference between the RAC and LC approaches in terms of morphine use doses (SMD = -0.27; 95%CI: -0.67–0.13; p = 0.18) [Fig. 11]. LOS measured in hours. the robot-assisted group demonstrated a trend toward a shorter hospital stay; however, the difference did not reach statistical significance Forest plot showing postoperative analgesia duration, expressed as the number of days of morphine use, comparing laparoscopic and robot-assisted cholecystectomy. While patients in the robot-assisted group required analgesia for a shorter period, the difference was not statistically significant Discussion This meta-analysis found no statistically significant differences between robotic-assisted cholecystectomy (RAC) and laparoscopic cholecystectomy (LC) in any of the evaluated clinical outcomes, including operative time, conversion rate to open surgery, intra- and postoperative complications, hospital stay duration, and morphine consumption. These results indicate that robotic cholecystectomy offers comparable safety and efficacy to the traditional laparoscopic approach. Although cholecystectomy is performed far less frequently in children than in adults, the growing prevalence of pediatric obesity has led to an increased occurrence of gallstone disease requiring surgical treatment. Additionally, the primary causes of cholelithiasis have shifted over time—from predominantly hemolytic disorders to diet-related factors [10]. Our meta-analysis revealed no statistically significant difference in operative time (OT) between robotic-assisted cholecystectomy (RAC) and laparoscopic cholecystectomy (LC). Because several of the included studies [1, 3] did not differentiate between single- and multi-port approaches in their statistical analyses, the number of ports was not considered in our OT comparison. Nonetheless, most patients underwent single-site robotic procedures. Kulaylat et al. [3] analyzed both multi-port and single-site RAC and LC separately and together, finding that laparoscopic single-incision (LSI) procedures required significantly more time than robotic single-incision (RSI) ones. Conversely, Mattei et al. [7], who compared RSI and LSI exclusively, observed longer OT in robotic cases. Direct comparisons remain difficult, as LC was often performed by residents in training, whereas RAC tended to be done by more experienced surgeons. Additionally, single-incision techniques—often preferred for cosmetic reasons—may inherently extend operative time [3]. It should also be noted that robotic-assisted surgery is still relatively new in pediatric practice. Kudsi et al. [11] examined the RAC learning curve using cumulative sum analysis, identifying a marked improvement in operative efficiency after approximately 84 cases, representing a key threshold for proficiency. We did not perform a formal cost analysis, as only one of the included studies provided cost-related data [3]. However, that study reported notably higher procedure costs for RAC compared with LC, suggesting a possible cost disadvantage of RAC that should be explored further in future research. In the studies included in this meta-analysis, all reported single-site RAC procedures were performed using one incision of a size varying between 2 and 4 cm, peri- or transumbilically, allowing for the introduction of the main port (8.5 mm) and usually one or two assistant’s ports (5 mm). This opening size is considerably larger than the typical multiport LC incisions (generally 10 mm + 3 × 5 mm). Despite the larger incision, several studies in both adult and pediatric patients reported high patient satisfaction, with less postoperative pain and favorable cosmetic outcomes associated with having a single scar compared to three or four scars in standard multiport LC procedures [7, 8, 12, 13]. We believe it is worth mentioning that patient satisfaction, while inherently subjective, provides valuable insight even if it cannot be objectively measured. Despite offering several advantages over conventional laparoscopy, robotic surgery has yet to gain widespread use in pediatric populations, primarily due to concerns about the smaller body size of children. However, gallstone disease in this group typically presents between 12.9 and 14.3 years of age, meaning that body size is less of a limiting factor for cholecystectomy [1–3, 7, 10, 11]. Although single-incision laparoscopic cholecystectomy (SILC) is considered both safe and feasible in children, it poses technical challenges, including limited working space, instrument crowding, reduced triangulation, longer operative times, and higher complication risks. Robotic-assisted techniques may help overcome these difficulties by providing superior visualization and improved instrument dexterity. The single-incision robotic cholecystectomy (SIRC) technique, for example, offers a 3D operative view and intuitive hand–instrument coordination, avoiding the counterintuitive movements required in SILC and allowing for greater precision in tight spaces [1, 3, 10]. Hey et al. [10], drawing on six years of experience with adolescent patients, reported that challenges related to the small operative field in pediatric robotic surgery can be mitigated through careful trocar placement and increased surgical experience. Regarding the learning curve, a study by Sheetz et al. [14] on RAC in adults showed that while increased experience correlates with fewer intraoperative complications, most U.S. surgeons perform too few robotic cholecystectomies to reach the same level of proficiency achieved with traditional laparoscopy—an issue that may extend to other countries as well. To our knowledge, this is the first meta-analysis comparing the effectiveness and efficiency of RAC versus LC in pediatric patients. The most recent meta-analysis on this topic in adults, conducted by Delgado et al. [15] in 2024, included 13 studies with approximately 22,440 participants. Their findings indicated that RAC was associated with longer operative times but showed no significant differences in length of stay (LOS), intraoperative or postoperative complications, or bile duct injuries compared to LC. These results differ somewhat from ours, likely due to variability in how OT was defined and measured across studies [1–3, 7, 10, 11], particularly regarding inclusion of preparation time. Nonetheless, our findings on safety and perioperative outcomes in pediatric patients are consistent with those reported in adults. However, the latest cohort study by Mullens et al. [16] conducted on over 700 000 patients, reported a significantly higher risk of bile duct injury in patients undergoing robotic-assisted cholecystectomy compared with laparoscopic cholecystectomy, while overall postoperative complication, reoperations and readmissions were similar between the groups. Another meta-analysis by Sun et al. [17] comparing SIRC and multi-port laparoscopic (MLP) cholecystectomy in adults found higher rates of incisional hernia and greater overall costs in the SIRC group. None of the pediatric studies we reviewed reported incisional hernias, but similarly to findings in adult studies, one of the included studies found higher procedure costs in the RAC group. Overall, clinical outcomes were comparable and align with previous literature. The main limitations of our meta-analysis stem from the designs of the included studies. Many were retrospective with small sample sizes, short follow-up durations, and reliance on historical controls. Another limitation is that one study included in our meta-analysis focused exclusively on acute patients (cholecystitis and/or choledocholithiasis) [8], and one study focused exclusively on elective cases [9], whereas the remaining studies either did not report whether and how many cases were acute or elective, or, even if they provided such data, analysed them together without differentiating into subgroups. It is possible that, had we been able to analyse acute and elective cases separately, the results might have differed. However, since most studies did not clearly distinguish between these groups, we analysed the cases together in accordance with the data provided by the original authors. A meta-analysis of randomized controlled trials (RCTs) would provide stronger evidence to evaluate this topic more definitively. Future research should prioritize RCTs, adopt standardized reporting methods with clearly defined outcome criteria, use the Clavien–Dindo classification for complications, and include extended follow-up beyond the immediate postoperative period. Conclusions Our analysis found no significant differences in available clinical outcome measures when comparing robotic-assisted surgery (RAS) to conventional laparoscopic minimally invasive surgery (MIS) for cholecystectomy in children. Based on the current literature, there is no conclusive evidence demonstrating clear clinical benefit of RAS over laparoscopic approach for cholecystectomy in pediatric patients. Similarly, no evidence-based contraindications have been documented. Therefore, the decision to use RAS should be based on the center’s capabilities, surgeon experience, and individual patient factors. Supplementary Information Below is the link to the electronic supplementary material. Supplementary file1. Abbreviations Laparoscopic cholecystectomy Robot- assisted cholecystectomy Length of hospital stay Operating time Cohort study The new ottawa scale No data Robotic single incision Randomized clinical trial Laparoscopic single incision Robotic-assisted surgery Robotic multiport Laparoscopic multiport Case–control study Single-incision laparoscopic cholecystectomy Author contributions Maria Klimeczek-Chrapusta: responsible for drafting the initial manuscript, managing data collection, conducting formal analyses, and overseeing project organization. Alicja Kot: contributed to manuscript preparation, data handling, and statistical analysis. Kacper Stolarz: involved in manuscript drafting, data management and analysis, project coordination, and software-based data processing. Bartosz Gęgała: reviewed and refined the final manuscript Maciej Preinl: participated in study design, data acquisition, analytical work, and initial manuscript writing. Zofia Łubniewska: engaged in study design, data preparation, and analytical evaluation. Anna Dąbrowska: contributed to statistical assessment and data interpretation. Bartosz Bogusz: provided supervision, validation of results, and manuscript review and editing. Maria Gruba: offered supervision, verified data accuracy, and assisted in manuscript revision and editing. Wojciech Górecki: supervised the project, validated findings, and critically reviewed and refined the final manuscript. Funding Polish Ministry of Science and Higher Education,European Funds For Social Development 2021-2027,Utilization of Advanced Technological Tools in Minimally Invasive Pediatric Surgery: Evaluation of Technique Effectiveness,Diagnostic Enhancement,and Innovation Promotion. ID: N6,Utilization of Advanced Technological Tools in Minimally Invasive Pediatric Surgery: Evaluation of Technique Effectiveness,Diagnostic Enhancement,and Innovation Promotion. ID: N6,Utilization of Advanced Technological Tools in Minimally Invasive Pediatric Surgery: Evaluation of Technique Effectiveness,Diagnostic Enhancement,and Innovation Promotion. ID: N6. Data availability Data available upon request. Declarations Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary file1. Data Availability Statement Data available upon request.